CymaBay Therapeutics Inc. (CBAY) slipped -5.3% or -0.58 to $10.36. It is near to 322673 shares traded, which is 68.51% compare to the average total volume 470990. The market cap of CBAY is $611.79 million. The year to date change is 16.25%. The 52 week price range is from $7.51 to $15.59. Price of CBAY have changed -4.12% during last week. It have changed -16.04% over last month, -20.90% over last 3 months, -1.80% over last 6 months and 42.08% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CBAY is 12.06. It is 16.41% above current price. The 200-day Moving Averages for CBAY is 12.22. It is 17.95% above current price. The 52-week High is 15.59. It is 50.48% from the current price. The 52-week Low is 7.51. It is -27.51% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CBAY is 15.57 on 2018-09-14. Short % to float is 10.25%. There are some statistics of CBAY. It is has market cap $611.79 million. The share outstanding is 59.05 million. The average volume is 470990. It has 102.17M cash and 6.81M in debt. The percent of top 15 Institution holding is 82.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CBAY is -47.48%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CBAY is -40.29%.